2023 in Numbers
2023 in Numbers: Celebrating the AD Knowledge Portal's Accomplishments The AD Knowledge Portal and Accelerating Medicines Partnership in Alzheimer’s Disease (AMP-AD) community accomplished a lot in 2023. AMP-AD and related consortia convened at conferences, participated in workshops, and collaborated in working groups dedicated [...]
AD Knowledge Portal at SfN 2023
We will be at SfN in DC in November 2023, exhibiting near the NIH at booth 3313 and answering questions at the following posters and sessions. Connect with us and learn more about resources available! Sunday, November 12 PSTR132.13 Inpp5d enhances Ab uptake, [...]
Closing the Knowledge Gap in AD
Expanding Representation of Alzheimer's Disease Data with Diverse Cohorts By Zoë Leanza A new release from the AD Knowledge Portal contributed genomic and transcriptomic data from underrepresented communities to researchers that study Alzheimer’s disease. Known as the [...]
Newly available transcriptome dataset identifies therapeutic targets for neurodegeneration
Lab of Nilüfer Ertekin-Taner Discovers Glial DDR2, STOM, and KANK2 as Therapeutic Targets in Progressive Supranuclear Palsy 🧠 by Zoë Leanza Three new therapeutic targets for progressive supranuclear palsy (PSP) have been identified by the lab of [...]